Rep. Nadler Issues Statement on Temporary Reauthorization & Study of Emergency Scheduling of Fentanyl Analogues Act
February 01, 2020
February 01, 2020
WASHINGTON, Feb. 1 -- Rep. Jerrold Nadler, D-New York, issued the following statement on Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act (S. 3201):
On Wednesday, I voted against adoption of S. 3201, the Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act, which the Senate passed on January 16.
It is absolutely true that the opioid crisis demands serious and appropriate action to address the . . .
On Wednesday, I voted against adoption of S. 3201, the Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act, which the Senate passed on January 16.
It is absolutely true that the opioid crisis demands serious and appropriate action to address the . . .